Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Health outcomes and cost of care among older adults with schizophrenia: a 10-year study using medical records across the continuum of care.

Hendrie HC, Tu W, Tabbey R, Purnell CE, Ambuehl RJ, Callahan CM.

Am J Geriatr Psychiatry. 2014 May;22(5):427-36. doi: 10.1016/j.jagp.2012.10.025. Epub 2013 Apr 6.

2.

Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery.

Rajji TK, Voineskos AN, Butters MA, Miranda D, Arenovich T, Menon M, Ismail Z, Kern RS, Mulsant BH.

Am J Geriatr Psychiatry. 2013 Feb;21(2):108-18. doi: 10.1016/j.jagp.2012.10.011. Epub 2013 Jan 22.

3.

Characterizing trajectories of cognitive functioning in older adults with schizophrenia: does method matter?

Thompson WK, Savla GN, Vahia IV, Depp CA, O'Hara R, Jeste DV, Palmer BW.

Schizophr Res. 2013 Jan;143(1):90-6. doi: 10.1016/j.schres.2012.10.033. Epub 2012 Dec 5.

4.

Neurocognitive performance stability in a multiplex multigenerational study of schizophrenia.

Roalf DR, Gur RC, Almasy L, Richard J, Gallagher RS, Prasad K, Wood J, Pogue-Geile MF, Nimgaonkar VL, Gur RE.

Schizophr Bull. 2013 Sep;39(5):1008-17. doi: 10.1093/schbul/sbs078. Epub 2012 Aug 27.

5.

What do we know about neuropsychological aspects of schizophrenia?

Palmer BW, Dawes SE, Heaton RK.

Neuropsychol Rev. 2009 Sep;19(3):365-84. doi: 10.1007/s11065-009-9109-y. Epub 2009 Jul 30. Review.

6.

Physical and mental health-related quality of life among older people with schizophrenia.

Folsom DP, Depp C, Palmer BW, Mausbach BT, Golshan S, Fellows I, Cardenas V, Patterson TL, Kraemer HC, Jeste DV.

Schizophr Res. 2009 Mar;108(1-3):207-13. doi: 10.1016/j.schres.2008.12.008. Epub 2009 Jan 24.

7.

Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder.

Depp CA, Savla GN, Moore DJ, Palmer BW, Stricker JL, Lebowitz BD, Jeste DV.

Bipolar Disord. 2008 Sep;10(6):684-90. doi: 10.1111/j.1399-5618.2008.00601.x.

8.

Antibodies to cytomegalovirus and Herpes Simplex Virus 1 associated with cognitive function in schizophrenia.

Shirts BH, Prasad KM, Pogue-Geile MF, Dickerson F, Yolken RH, Nimgaonkar VL.

Schizophr Res. 2008 Dec;106(2-3):268-74. doi: 10.1016/j.schres.2008.07.017. Epub 2008 Sep 17.

9.

Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling.

Barnett JH, Croudace TJ, Jaycock S, Blackwell C, Hynes F, Sahakian BJ, Joyce EM, Jones PB.

BMC Psychiatry. 2007 May 9;7:16.

10.

Supplemental Content

Support Center